Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/08/2023 | Generation Bio Co. | GBIO | Grant | Stock Option (right to buy) | 25k | $4.83 | $120.8k | | 06/08/2023 |
06/09/2022 | Generation Bio Co. | GBIO | Grant | Stock Option (right to buy) | 19.2k | $6.19 | $118.8k | | 06/09/2022 |
03/16/2022 | Aeglea BioTherapeutics, Inc. | AGLE | Purchase | Common Stock | 80.1k | $2.34 | $187.7k | | 03/16/2022 |
03/15/2022 | Aeglea BioTherapeutics, Inc. | AGLE | Purchase | Common Stock | 42.4k | $1.86 | $78.9k | | 03/11/2022 |
03/14/2022 | Aeglea BioTherapeutics, Inc. | AGLE | Purchase | Common Stock | 67.5k | $1.93 | $130.2k | | 03/11/2022 |
03/11/2022 | Aeglea BioTherapeutics, Inc. | AGLE | Purchase | Common Stock | 34.8k | $2.06 | $71.8k | | 03/11/2022 |
02/17/2022 | Aeglea BioTherapeutics, Inc. | AGLE | Grant | Employee Stock Option (right to buy) | 350k | $3.17 | $1.1M | | 02/17/2022 |
12/10/2021 | Aeglea BioTherapeutics, Inc. | AGLE | Purchase | Common Stock | 10.5k | $3.75 | $39.5k | | 12/09/2021 |
12/09/2021 | Aeglea BioTherapeutics, Inc. | AGLE | Purchase | Common Stock | 43.1k | $3.70 | $159.5k | | 12/09/2021 |
10/28/2021 | Generation Bio Co. | GBIO | Gift | Common Stock | 72.8k | $0.00 | $0 | | 10/28/2021 |
10/28/2021 | Generation Bio Co. | GBIO | Gift | Common Stock | 72.8k | $0.00 | $0 | By Trust | 10/28/2021 |
06/30/2021 | Kaleido Biosciences, Inc. | KLDO | Grant | Stock Option (Right to Buy) | 15k | $7.44 | $111.6k | | 06/30/2021 |
06/09/2021 | Generation Bio Co. | GBIO | Grant | Stock Option (right to buy) | 15k | $26.59 | $398.8k | | 06/09/2021 |
02/17/2021 | Aeglea BioTherapeutics, Inc. | AGLE | Grant | Employee Stock Option (right to buy) | 330k | $7.35 | $2.4M | | 02/17/2021 |
06/30/2020 | Kaleido Biosciences, Inc. | KLDO | Grant | Stock Option (Right to Buy) | 15k | $7.43 | $111.4k | | 06/30/2020 |
06/16/2020 | Generation Bio Co. | GBIO | Conversion | Common Stock | 30.4k | $0.00 | $0 | | 06/16/2020 |
06/16/2020 | Generation Bio Co. | GBIO | Conversion | Series C Preferred Stock | 53.7k | $0.00 | $0 | | 06/16/2020 |
06/11/2020 | Generation Bio Co. | GBIO | Grant | Stock Option (right to buy) | 52k | $19.00 | $988k | | 06/11/2020 |
04/30/2020 | Aeglea BioTherapeutics, Inc. | AGLE | Purchase | Common Stock | 165k | $4.75 | $783.8k | | 04/30/2020 |
02/14/2020 | Aeglea BioTherapeutics, Inc. | AGLE | Grant | Employee Stock Option (right to buy) | 301k | $8.15 | $2.5M | | 02/14/2020 |
10/04/2019 | Aeglea BioTherapeutics, Inc. | AGLE | Exercise | Stock Option (right to buy) | 662 | $5.46 | $3.6k | | 10/04/2019 |
10/04/2019 | Aeglea BioTherapeutics, Inc. | AGLE | Exercise | Stock Option (right to buy) | 17.6k | $6.31 | $111.1k | | 10/04/2019 |
06/14/2019 | Aeglea BioTherapeutics, Inc. | AGLE | Purchase | Common Stock | 5.3k | $6.23 | $32.9k | | 06/12/2019 |
06/13/2019 | Aeglea BioTherapeutics, Inc. | AGLE | Purchase | Common Stock | 14.4k | $6.17 | $88.8k | | 06/12/2019 |
06/12/2019 | Aeglea BioTherapeutics, Inc. | AGLE | Purchase | Common Stock | 12.2k | $6.11 | $74.7k | | 06/12/2019 |
05/22/2019 | Aeglea BioTherapeutics, Inc. | AGLE | Purchase | Common Stock | 3.8k | $6.86 | $26.1k | | 05/20/2019 |
05/21/2019 | Aeglea BioTherapeutics, Inc. | AGLE | Purchase | Common Stock | 13.8k | $6.89 | $95k | | 05/20/2019 |
05/20/2019 | Aeglea BioTherapeutics, Inc. | AGLE | Purchase | Common Stock | 9k | $6.56 | $58.9k | | 05/20/2019 |
05/17/2019 | Aeglea BioTherapeutics, Inc. | AGLE | Purchase | Common Stock | 6.2k | $6.65 | $41.3k | | 05/15/2019 |
05/16/2019 | Aeglea BioTherapeutics, Inc. | AGLE | Purchase | Common Stock | 5.5k | $6.83 | $37.7k | | 05/15/2019 |
05/15/2019 | Aeglea BioTherapeutics, Inc. | AGLE | Purchase | Common Stock | 6.3k | $6.76 | $42.3k | | 05/15/2019 |
03/04/2019 | Kaleido Biosciences, Inc. | KLDO | Conversion | Common Stock | 12.9k | $0.00 | $0 | | 03/04/2019 |
03/04/2019 | Kaleido Biosciences, Inc. | KLDO | Conversion | Series B Preferred Stock | 25.7k | $0.00 | $0 | | 03/04/2019 |
02/28/2019 | Aeglea BioTherapeutics, Inc. | AGLE | Grant | Stock Option (right to buy) | 280k | $8.36 | $2.3M | | 02/28/2019 |
02/15/2019 | Aeglea BioTherapeutics, Inc. | AGLE | Purchase | Common Stock | 719 | $7.10 | $5.1k | | 05/15/2019 |
|